Risk of Unsatisfactory Functional Outcome of Stroke in Patients with Clinical Manifestation of Persistent Viral Infection


Т. М. Черенько
Н. С. Турчина
С. Л. Рибалко
Д. І. Старосила


Acute cerebrovascular disorders represent up to 75–85 % of strokes inUkraine. The wide spread of herpesvirus infection in developing countries (with a prevalence of 35–40 %), as well as influenza virus, requires consideration of the viral risk factor of stroke for prognostic purposes.

The objective: to study the influence of the most common types of viral infection: the family of herpesviruses and influenza virus on the neurological and one-year functional outcome of stroke and to determine the predictors of unsatisfactory recovery of patients.

Materials and methods. In the period from 2016–2020, on the basis of the neurological departments ofAlexanderHospital andClinicalHospital № 4 we performed research on the presence of herpes viruses. 70 patients with ischemic stroke with moderate and severe neurological disorders were examined, in whom herpes and influenza viruses were detected in the blood (the main group) within 2 weeks before hospitalization against the background of viral manifestation. The comparison group consisted of 220 patients without clinical signs of viral manifestations were compared with the main group by stroke severity, average age and gender. The severity of neurological disorders was assessed by the NIHSS scale. Functional recovery was assessed by the Barthel index. The presence of viral infection (family of herpesviruses and influenza virus) was studied using polymerase chain reaction.

Results. HSV1 DNA was detected in 43 (61.4 %) cases, HSV2 – in 30 (42.9 %), EBV4 – in 19 (27.1 %), CMV5 – in 18 (25.7 %), HNV6 – in 27 (38.6 %), Influenza RNA – in 16 (22.9 %). Only one type of virus was present in 21 (30.0 %) patients, two types of viruses were identified in 31 (44.3 %), three or more types of viruses – in 18 (25.7 %). In the presence of viral infection, the relative risk of unsatisfactory recovery of neurological functions in the main group increases 1.99 times relative to the comparison group: RR=1.99 (95 % CI: 1.60–2.48). The presence of viral infection predicted unsatisfactory recovery with a sensitivity of 74.3 %, a specificity of 62.7 % and an area under the curve ROC=0.69. There was a negative correlation between increasing the number of virus types in patients and the lack of neurological improvement: r=0.370 (p=0.002). The presence of viral infection significantly increased the risk of moderate and severe disability one year after stroke, the relative risk of disability in patients of the main group relative to patients of comparison group was: RR=1,668 (95 % CI: 1,256–2,214), and IB score according to the linear regression analysis inversely depended on the number of viruses in patients, linear R2=0.423 (correlation coefficient r=–0.660). In the presence of two types of viruses in the blood, the probability of unsatisfactory recovery increased – 1.5 times (RR=1,562; 95 % CI: 1,064–2,265), three or more viruses 2.5 times (RR=2,511; 95 % CI: 1,888–3,340). One year after stroke, there was a significant correlation between lower IB score and the presence of HSV1 in associations: r=0.323; CMV: r=0.351; EBV: r=0.430. If there are at least 2 types of viruses in the blood, in particular HSV1+CMV and HHV6+CMV, the relative risk of PI and TI increases 2.9 times.

Conclusions. The presence of a viral infection significantly increases the risk of unsatisfactory regression of neurological disorders, allows to predict poor neurological recovery with a sufficiently high sensitivity and specificity. In patients with viral manifestations and detection of the virus in the blood, functional recovery one year after stroke is significantly worse than in patients without it; this applies to a lower mean score of IB and the percentage of patients with minimal limitation of function. When the number of persistent viruses increases to two or more, the relative risk of PI and TI increases one year after stroke, with the highest rate in the presence of EBV and CMV associations. If there are at least 2 types of viruses in the blood, in particular HSV1+CMV, HHV6+CMV, HSV1+EBV the relative risk of PI and TI increases 2.9 times.


How to Cite
Черенько, Т. М., Турчина, Н. С., Рибалко, С. Л., & Старосила, Д. І. (2020). Risk of Unsatisfactory Functional Outcome of Stroke in Patients with Clinical Manifestation of Persistent Viral Infection. Family Medicine, (4), 45–51. https://doi.org/10.30841/2307-5112.4.2020.217491
For practicing physicians
Author Biographies

Т. М. Черенько, Bogomolets National Medical University

Tetiana M. Cherenko,

Department of Neurology

Н. С. Турчина, Bogomolets National Medical University

Nataliia S. Turchina,

Department of Neurology

С. Л. Рибалко, L. V. Hromashevsky Institute of Epidemiology and Infectious Diseases of the NAMS of Ukraine

Svitlana L. Rybalko,

Head of Laboratory of Experimental Chemotherapy of Viral Infections

Д. І. Старосила, L. V. Hromashevsky Institute of Epidemiology and Infectious Diseases of the NAMS of Ukraine

Daria B. Starosyla,

Laboratory of Experimental Chemotherapy of Viral Infections


Feigin VL et al. Global burden of stroke and risk factors in 188 countries, during 1990–2013: asystematic analysis for the Global Burden of Disease Study 2013. Lancet 2016. – Vol. 15, No. 9, p. 913–924.

Зозуля І.С. Епідеміологія цереброваскулярних захворювань в Україні / І.С. Зозуля, А.І. Зозуля // Укр. мед. часопис. – 2011. – № 5. – С. 36–41.

Кузнецов А.Н. Ишемический инсульт: диагностика, лечение и профилактика / А.Н. Кузнецов, О.И. Виноградов, С.С. Кучеренко. – М. : РАЕН, 2012. – 89 с.

Chiu L., Pai L., Shyu W.C., Jayne Chen T.R., Chang T.P. Analysis of costs borne by families of patients hospitalized for stroke. Zhonghua Yi Xue Za Zhi (Taipei). 1998, 61, 267–275.

The Burden of Stroke in Europe report conducted by King’s College London for the Stroke Alliance for Europe. 2015. URL: http://www.strokeeurope.eu/downloads/The_Burden_of_Stroke_in_Europe_Report_Appendix.pdf.

Черенько Т.М. Неврологічне та функціональне відновлення після ішемічного інсульту в різні періоди: їх зв’язок з рівнем нейроспецифічного маркеру S-100 // Український неврологічний журнал. – 2015. – № 4. – С. 5–9.

Черенько Т.М., Гелетюк Ю.Л. Прогнозування функціональних наслідків мозкового ішемічного інсульту через рік після його виникнення // Серце і судини. – 2018. – № 3. – C. 28–35.

Manolio T.A., Kronmal R.A., Burke G.L., O’Leary D.H., Price T.R., Short-term predictors of incident stroke in older adults. The Cardiovascular Health Study. Stroke 1996, 27, 1479–1486.

Wolf P.A., D’Agostino R.B., O’Neal M.A., Sytkowski P., Kase C.S., Belanger A.J., Kannel W.B., Secular trends in stroke incidence and mortality. The Framingham Study. Stroke 1992, 23, 1551–1555.

Sharma J.C., Fletcher S., Vassallo M., 1999. Strokes in the elderly – higher acute and 3-month mortality – an explanation. Cerebrovasc. Dis. 1999, 9, 2–9.

Lee M., Huang W.Y., Weng H.H., Lee J.D., Lee T.H. First-ever ischemic stroke in very old Asians: clinical features, stroke subtypes, risk factors and outcome. Eur. Neurol. 2007, 58, 44–48.

Lin J.H., Hsieh C.L., Lo S.K., Hsiao S.F., Huang M.H., Prediction of functional outcomes in stroke inpatients receiving rehabilitation. J. Formos. Med. Assoc. 2003, 102, 695–700.

Appelros P, Nydevik I, Viitanen M. Poor Outcome After First-Ever Stroke: Predictors for Death, Dependency, and Recurrent Stroke Within the First Year. Stroke 2003, 34: 122–126.

Veerbeek JM, Kwakkel G, van Wegen EE, Ket JC, Heymans MW. Early prediction of outcome of activities of daily living after stroke: a systematic review. Stroke. 2011 May; 42(5):1482–8.

Fahey M., Crayton Е., Wolfe С., Douiri А. Clinical prediction models formortality and functional outcome following ischemic stroke: A systematic review and meta-analysis PLoS One. 2018; 13(1): e0185402. doi: 10.1371/journal.pone.0185402

Malkin J.-E. Epidemiology of genital herpes simplex virus infection in developed countries. Herpes, 2004, vol. 11, supplement 1,pp. 2A–23A

Esenwa C.C., Elkind M.S. Inflammatory risk factors, biomarkers and associated therapy in ischaemic stroke. Nature Reviews Neurology 2016. 12:594–604.

Forbes, Harriet J., Elizabeth Williamson, Laura Benjamin, Judith Breuer, Martin M. Brown, Sineґad M. Langan, Caroline Minassian Liam Smeeth, Sara L. Thomas, Charlotte Warren-Gash. Association of herpesviruses and stroke: Systematic review and meta-analysis PLoS One. 2018 Nov 21;13(11):e0206163. doi: 10.1371/journal.pone.0206163.

Wu YP, Sun DD, Wang Y, Liu W, Yang J. Herpes Simplex Virus Type 1 and Type 2 Infection Increases Atherosclerosis Risk: Evidence Based on a Meta-Analysis. Biomed Res Int. 2016;2016:2630865. doi:10.1155/2016/2630865

Liu X.C., Guan Y.M., Hou L., et al. The Short- and Long-Term Risk of Stroke after Herpes Zoster: A Meta-Analysis. Plos One 2016.11

Wang H., Peng G., Bai J., Не В., Kecheng Н., Нu X., Liu D. Сytomegalovirus Infection and Relative Risk of Cardiovascular Disease (Ischemic Heart Disease, Stroke, and Cardiovascular Death): A Meta‐Analysis of Prospective Studies Up to 2016 / Journal of the American Heart Association. 2017 Jul; 6(7): e005025 doi: 10.1161/JAHA.116.005025

Odderson IR. The National Institutes of Health Stroke Scale and its importance in acute stroke management. Phys Med Rehabil Clin N Am. 1999: 10(4):787–800.

Mahoney F.I., Barthel D.W. Functional evaluation: The Barthel indeх // Md. State. Med. J. – 1965. – Vol. 14. – P. 61–65.